sham-control group

DEVICE4 trials

Sponsors

The First Affiliated Hospital with Nanjing Medical University, Suzhou Municipal Hospital

Conditions

Blood PressureCardiovascular DiseasesHypertensionNon-alcoholic Fatty Liver Disease

Unknown Phase

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension

TerminatedNCT05049096

The First Affiliated Hospital with Nanjing Medical UniversityBlood Pressure, Cardiovascular Diseases, Hypertension

Start: 2021-11-01End: 2023-11-20Updated: 2023-12-07

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE-HTN-II)

CompletedNCT06018493

The First Affiliated Hospital with Nanjing Medical UniversityBlood Pressure, Cardiovascular Diseases, Hypertension

Start: 2023-09-01End: 2025-04-20Updated: 2026-02-27

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)

RecruitingNCT06225713

The First Affiliated Hospital with Nanjing Medical UniversityNon-alcoholic Fatty Liver Disease

Start: 2024-02-02End: 2024-12-31Target: 80Updated: 2024-06-13

Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension (PARADISE HTN-III)

RecruitingNCT06283758

Suzhou Municipal HospitalBlood Pressure, Cardiovascular Diseases, Hypertension

Start: 2024-03-01End: 2026-10-01Target: 30Updated: 2026-01-23

Related Papers

Perirenal fat as a potential marker and therapeutic target for metabolic syndrome: insights from a multicenter randomized controlled trial.

2025-05-23

Effect of focused power ultrasound-mediated perirenal fat modification on primary hypertension: protocol of a multicenter, randomized, double-blinded, sham-controlled study.

2023-03-235 citations